Poland· PL-100259924
Tenaxum
A rilmenidine product containing rilmenidinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rilmenidine is registered in 3 of 19 countries.
Countries holding a registration under ATC C02AC06 (rilmenidine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rilmenidine · ATC C02AC06
3 / 19 countries
- Czechiaprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Rilmenidinum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C02AC06
- ATC class
- Rilmenidine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909997076157
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rilmenidine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRILMENIDIN TEVATeva Pharmaceuticals CR, s.r.o., Praha
- FranceHYPERIUM 1 mg, compriméLES LABORATOIRES SERVIER
- United KingdomHyperium 1mg tabletsImported (France)
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Iterium, Rilmenidin Grindeks
- Bulgaria · Рилменидин Гриндекс, Рилменикс
- Czechia · Rilmenidin Teva, Rilmenidine Grindeks
- Estonia · Rilmenidine Grindeks
- France · Hyperium, Rilmenidine Arrow
- Hungary · Hyperlex, Rilmenidin Teva
- Lithuania · Rilmenidine Grindeks, Rilmenidine Teva
- Luxembourg · Hyperium
- Latvia · Rilmenidine Grindeks, Rilmenidine Teva
- Portugal · Hyperium, Rilmenidina Grindeks
- Romania · Rilmenidină Grindeks, Taruza
- Slovakia · Rilmenidin Teva, Rilmenidine Grindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8b66618-95a8-4706-8915-1bebb2b8982b GET /v1/drugs/b8b66618-95a8-4706-8915-1bebb2b8982b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "1 mg",
"packaging": "05909997076157 ¦ Rp ¦ 70570\n30 tabl.",
"substance": null,
"common_name": "Rilmenidinum",
"pl_product_id": "100259924",
"pozwolenie_nr": "157/10",
"auth_procedure": "IR",
"authorisation_validity": "2030-10-05"
}See everything about rilmenidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.